Short answer
Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Earnings release covers Surgery Partners’ three and nine months ended September 30, 2026.
Surgery Partners, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers Surgery Partners’ three and nine months ended September 30, 2026
- Investors should review Exhibit 99.1 for operating results, financial condition, and management commentary
- Non-GAAP measures included with reconciliations to comparable GAAP figures, supporting adjusted-performance analysis
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $815.3M, down 0.8%, while same-facility revenue grew 6.0% on 5.8% higher revenue per case
- Adjusted EBITDA $132.7M, down from $136.4M, with margin declining to 16.3% from 16.6%
- Net loss attributable to Surgery Partners $21.1M, versus $22.7M, while adjusted EPS increased to $0.16 from $0.13
- HealthSpan merger consideration raised to $25.00 per share, implying enterprise value up to approximately $6.0B
- Stockholders receive a 10% annual ticking fee after March 1, 2027 if approval occurs but closing is delayed; merger expected in Q1 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Surgery Partners, Inc. 8-K filings
Get the next SGRY 8-K as it lands
Follow SGRY for push alerts, or ask the research agent what this filing means.